PL2844659T3 - Pochodne pirrolotriazynonowe - Google Patents
Pochodne pirrolotriazynonoweInfo
- Publication number
- PL2844659T3 PL2844659T3 PL13714859.9T PL13714859T PL2844659T3 PL 2844659 T3 PL2844659 T3 PL 2844659T3 PL 13714859 T PL13714859 T PL 13714859T PL 2844659 T3 PL2844659 T3 PL 2844659T3
- Authority
- PL
- Poland
- Prior art keywords
- pyrrolotriazinone derivatives
- pyrrolotriazinone
- derivatives
- Prior art date
Links
- BEBRHYJBTAMGRW-UHFFFAOYSA-N pyrrolo[3,2-d]triazin-4-one Chemical class O=C1N=NN=C2C=CN=C12 BEBRHYJBTAMGRW-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12003445 | 2012-05-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2844659T3 true PL2844659T3 (pl) | 2016-11-30 |
Family
ID=48050660
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13714859.9T PL2844659T3 (pl) | 2012-05-04 | 2013-04-06 | Pochodne pirrolotriazynonowe |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US9174995B2 (pl) |
| EP (1) | EP2844659B1 (pl) |
| JP (1) | JP6097820B2 (pl) |
| KR (1) | KR20150006873A (pl) |
| CN (1) | CN104271580B (pl) |
| AR (1) | AR090896A1 (pl) |
| AU (1) | AU2013257018B2 (pl) |
| CA (1) | CA2872334C (pl) |
| EA (1) | EA027628B1 (pl) |
| ES (1) | ES2587939T3 (pl) |
| HR (1) | HRP20161033T1 (pl) |
| HU (1) | HUE028325T2 (pl) |
| IL (1) | IL235414A (pl) |
| MX (1) | MX357502B (pl) |
| PL (1) | PL2844659T3 (pl) |
| PT (1) | PT2844659T (pl) |
| RS (1) | RS55062B1 (pl) |
| SG (1) | SG11201406997WA (pl) |
| SI (1) | SI2844659T1 (pl) |
| WO (1) | WO2013164061A1 (pl) |
| ZA (1) | ZA201408876B (pl) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013132253A1 (en) | 2012-03-07 | 2013-09-12 | Institute Of Cancer Research: Royal Cancer Hospital (The) | 3-aryl-5-substituted-isoquinolin-1-one compounds and their therapeutic use |
| EP3044221B1 (en) | 2013-09-11 | 2018-02-21 | Institute of Cancer Research: Royal Cancer Hospital (The) | 3-aryl-5-substituted-isoquinolin-1-one compounds and their therapeutic use |
| PL3087076T3 (pl) * | 2013-12-23 | 2018-01-31 | Merck Patent Gmbh | Pochodne imidazopirazynonowe |
| UY36060A (es) | 2014-04-02 | 2015-10-30 | Bayer Pharma AG | Compuestos de azol sustituidos con amida |
| PT3130592T (pt) * | 2014-04-10 | 2019-11-21 | Hubei Bio Pharmaceutical Industrial Tech Institute Inc | Análogos do composto 4h-pirazolo[1,5-]benzimidazole como inibidores de parp |
| KR20160007347A (ko) * | 2014-07-11 | 2016-01-20 | 에스티팜 주식회사 | 신규한 이미다조트리아지논 또는 이미다조피라지논 유도체, 및 이들의 용도 |
| KR101775356B1 (ko) * | 2015-07-06 | 2017-09-06 | 재단법인 아산사회복지재단 | Parp 및 탄키라제 동시 저해제에 대한 감수성 결정 방법 |
| ES2969565T3 (es) * | 2015-09-30 | 2024-12-13 | Max Planck Ges Zur Foerderung Derwissenschaften E V | Derivados heteroarílicos como inhibidores de la sepiapterina reductasa |
| WO2017055313A1 (en) | 2015-10-01 | 2017-04-06 | Bayer Pharma Aktiengesellschaft | Amido-substituted azole compounds |
| WO2017055316A1 (en) | 2015-10-01 | 2017-04-06 | Bayer Pharma Aktiengesellschaft | Amido-substituted azole compounds |
| SG11201802710YA (en) | 2015-11-16 | 2018-06-28 | Topadur Pharma Ag | 2-phenyl-3,4-dihydropyrrolo[2,1 -f] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereof |
| US10722484B2 (en) | 2016-03-09 | 2020-07-28 | K-Gen, Inc. | Methods of cancer treatment |
| WO2018078005A1 (en) | 2016-10-29 | 2018-05-03 | Bayer Pharma Aktiengesellschaft | Amido-substituted azaspiro derivatives as tankyrase inhibitors |
| WO2018078009A1 (en) | 2016-10-29 | 2018-05-03 | Bayer Pharma Aktiengesellschaft | Amido-substituted cyclohexane derivatives |
| WO2018087126A1 (en) | 2016-11-09 | 2018-05-17 | Bayer Pharma Aktiengesellschaft | Amido-substituted cyclohexane derivatives as inhibitors of tankyrase |
| CN109180702B (zh) * | 2018-10-29 | 2021-11-30 | 四川大学 | 一种噻吩并嘧啶酮化合物及其用途 |
| CN111961058B (zh) * | 2020-08-03 | 2022-12-16 | 天津全和诚科技有限责任公司 | 4-氨基-吡咯并三嗪衍生物及其制备方法和用途 |
| EP4504341A1 (en) | 2022-04-08 | 2025-02-12 | Shy Therapeutics LLC | Compounds that interact with ras superfamily proteins for treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
| WO1997030035A1 (en) | 1996-02-13 | 1997-08-21 | Zeneca Limited | Quinazoline derivatives as vegf inhibitors |
| ES2169355T3 (es) | 1996-03-05 | 2002-07-01 | Astrazeneca Ab | Derivados de 4-anilinoquinazolina. |
| GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
| GB9714249D0 (en) | 1997-07-08 | 1997-09-10 | Angiogene Pharm Ltd | Vascular damaging agents |
| GB9900334D0 (en) | 1999-01-07 | 1999-02-24 | Angiogene Pharm Ltd | Tricylic vascular damaging agents |
| GB9900752D0 (en) | 1999-01-15 | 1999-03-03 | Angiogene Pharm Ltd | Benzimidazole vascular damaging agents |
| IL152682A0 (en) | 2000-05-31 | 2003-06-24 | Astrazeneca Ab | Indole derivatives with vascular damaging activity |
| HUP0301742A3 (en) | 2000-07-07 | 2005-08-29 | Angiogene Pharm Ltd | Colchinol derivatives as angiogenesis inhibitors, process for producing them, pharmaceutical compositions containing them and their use |
| BR0112224A (pt) | 2000-07-07 | 2003-06-10 | Angiogene Pharm Ltd | Composto, composição farmacêutica, uso de um composto ou de um sal, solvato ou pró-droga farmaceuticamente aceitável do mesmo, e, processo para preparar um composto |
| CA2520465A1 (en) * | 2003-03-28 | 2004-10-14 | Scios Inc. | Bi-cyclic pyrimidine inhibitors of tgf.beta. |
| AP2007003923A0 (en) * | 2004-09-30 | 2007-02-28 | Tibotec Pharm Ltd | Hcv inhibiting bi-cyclic pyrimidines |
| WO2008092861A1 (en) | 2007-01-30 | 2008-08-07 | Janssen Pharmaceutica N.V. | Bicyclic derivatives as ep4 agonists |
| HRP20120346T1 (hr) | 2007-03-08 | 2012-05-31 | Janssen Pharmaceutica N.V. | Derivati kinolinona kao parp i tank inhibitori |
| EP2134716A1 (en) * | 2007-04-18 | 2009-12-23 | Bristol-Myers Squibb Company | Pyrrolotriazine kinase inhibitors |
-
2013
- 2013-04-06 JP JP2015509321A patent/JP6097820B2/ja not_active Expired - Fee Related
- 2013-04-06 PT PT137148599T patent/PT2844659T/pt unknown
- 2013-04-06 CN CN201380023419.2A patent/CN104271580B/zh not_active Expired - Fee Related
- 2013-04-06 US US14/398,212 patent/US9174995B2/en not_active Expired - Fee Related
- 2013-04-06 WO PCT/EP2013/001026 patent/WO2013164061A1/en not_active Ceased
- 2013-04-06 SG SG11201406997WA patent/SG11201406997WA/en unknown
- 2013-04-06 RS RS20160696A patent/RS55062B1/sr unknown
- 2013-04-06 HR HRP20161033TT patent/HRP20161033T1/hr unknown
- 2013-04-06 MX MX2014013090A patent/MX357502B/es active IP Right Grant
- 2013-04-06 EA EA201401212A patent/EA027628B1/ru not_active IP Right Cessation
- 2013-04-06 CA CA2872334A patent/CA2872334C/en active Active
- 2013-04-06 SI SI201330275A patent/SI2844659T1/sl unknown
- 2013-04-06 KR KR1020147033753A patent/KR20150006873A/ko not_active Ceased
- 2013-04-06 ES ES13714859.9T patent/ES2587939T3/es active Active
- 2013-04-06 EP EP13714859.9A patent/EP2844659B1/en active Active
- 2013-04-06 PL PL13714859.9T patent/PL2844659T3/pl unknown
- 2013-04-06 AU AU2013257018A patent/AU2013257018B2/en not_active Ceased
- 2013-04-06 HU HUE13714859A patent/HUE028325T2/en unknown
- 2013-04-30 AR ARP130101468A patent/AR090896A1/es unknown
-
2014
- 2014-10-30 IL IL235414A patent/IL235414A/en active IP Right Grant
- 2014-12-03 ZA ZA2014/08876A patent/ZA201408876B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2013164061A1 (en) | 2013-11-07 |
| EP2844659B1 (en) | 2016-05-25 |
| MX2014013090A (es) | 2014-12-08 |
| SG11201406997WA (en) | 2014-11-27 |
| JP6097820B2 (ja) | 2017-03-15 |
| HK1205740A1 (en) | 2015-12-24 |
| SI2844659T1 (sl) | 2016-10-28 |
| JP2015515961A (ja) | 2015-06-04 |
| AU2013257018A1 (en) | 2014-12-18 |
| US9174995B2 (en) | 2015-11-03 |
| ZA201408876B (en) | 2017-06-28 |
| EA201401212A1 (ru) | 2015-08-31 |
| ES2587939T3 (es) | 2016-10-27 |
| CA2872334A1 (en) | 2013-11-07 |
| CN104271580A (zh) | 2015-01-07 |
| AR090896A1 (es) | 2014-12-17 |
| HUE028325T2 (en) | 2016-12-28 |
| MX357502B (es) | 2018-07-12 |
| US20150133453A1 (en) | 2015-05-14 |
| CN104271580B (zh) | 2017-02-22 |
| CA2872334C (en) | 2020-06-30 |
| WO2013164061A8 (en) | 2014-11-06 |
| AU2013257018B2 (en) | 2017-02-16 |
| HRP20161033T1 (hr) | 2016-10-21 |
| PT2844659T (pt) | 2016-08-31 |
| RS55062B1 (sr) | 2016-12-30 |
| KR20150006873A (ko) | 2015-01-19 |
| IL235414A (en) | 2017-11-30 |
| EP2844659A1 (en) | 2015-03-11 |
| EA027628B1 (ru) | 2017-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201409422B (en) | Benzimidazole-proline derivatives | |
| DK2830816T3 (en) | Hidtil ukendt coatingkoncept | |
| DK3327112T3 (en) | Agse-deficient stamme | |
| ZA201408876B (en) | Pyrrolotriazinone derivatives | |
| EP2935220A4 (en) | PERI-carbinol | |
| PL2838883T3 (pl) | Nowe pochodne fenylo-tetrahydroizochinoliny | |
| ZA201502175B (en) | Oxazolidin-2-one-pyrimidine derivatives | |
| IL236295A (en) | The history of indanesulfamide | |
| EP2920142A4 (en) | MÉTHANOFULLERRÈNES | |
| ZA201405108B (en) | Substituted phenylazole derivative | |
| PT2873660T (pt) | Derivado de indolecarboxamida | |
| SG11201404325VA (en) | Pyrimidooxazocine derivatives as mtor - inhibitors | |
| GB201220388D0 (en) | Vertergo | |
| AU345893S (en) | Treehouse | |
| GB201212003D0 (en) | Dynodisc | |
| GB201209917D0 (en) | ProCap | |
| GB201202208D0 (en) | Easomark | |
| GB201201767D0 (en) | Pop-tops | |
| GB201201668D0 (en) | LOCnlatch | |
| GB201201023D0 (en) | Sharkbitze | |
| GB201201085D0 (en) | Hit-a-pair | |
| GB201200939D0 (en) | Drinc-pinc | |
| GB201200608D0 (en) | Torsocooler | |
| GB201200644D0 (en) | Visualiser | |
| GB201200467D0 (en) | Coda251 |